Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Emaretamig

😃Good
Catalog No. T9901A-1873Cas No. 3051701-97-1

Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.

Emaretamig

Emaretamig

😃Good
Catalog No. T9901A-1873Cas No. 3051701-97-1
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor that targets CLDN18 and CD3E. Abdakibart is applicable for cancer research related to gastric and pancreatic cancers.
Chemical Properties
Cas No.3051701-97-1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Emaretamig | purchase Emaretamig | Emaretamig cost | order Emaretamig